<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02800252</url>
  </required_header>
  <id_info>
    <org_study_id>NCSFOSJC</org_study_id>
    <nct_id>NCT02800252</nct_id>
  </id_info>
  <brief_title>Effects of Omega-3 Plus Low-dose Aspirin as Adjunct to Periodontal Debridement for Chronic Periodontitis in Diabetics</brief_title>
  <official_title>Effects of Omega-3 Polyunsaturated Fatty Acids Daily Supplementation Plus Low-dose Aspirin as Adjunct to Full-mouth Periodontal Ultrasonic Debridement for the Treatment of Chronic Periodontitis in Type 2 Diabetics: Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidade Estadual Paulista Júlio de Mesquita Filho</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fundação de Amparo à Pesquisa do Estado de São Paulo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universidade Estadual Paulista Júlio de Mesquita Filho</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Therefore, the aim of this study is to investigate the effectiveness of daily supplementation
      of omega-3 polyunsaturated fatty acids and low-dose aspirin as adjunct therapy to one-stage
      full-mouth periodontal ultrasonic debridement for the treatment of chronic periodontitis in
      type 2 diabetic patients through a superiority randomized clinical trial.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Diabetes mellitus (DM) has become a global epidemic. Its complications can have a significant
      impact on quality of life, longevity, and costs in public health. The World Health
      Organization (WHO) estimates that by 2040, 642 million people will suffer from diabetes,
      around 10% of the world adult population (WHO, 2015). Periodontal Diseases are considered the
      sixth complication of DM. This close relationship between both diseases is characterized by
      mutual influence. Thus, an appropriate control of periodontal disease may facilitate the DM
      control, improving quality of life on diabetic patients. Besides that, the presence of DM
      might impair prognosis of diverse dental treatments due to its inflammatory nature, negative
      influence on wound healing, on bone biology, and the establishment of infections. As a host
      modulatory therapy (HMT), the daily supplementation of omega-3 polyunsaturated fatty acids
      and low-dose aspirin has been proposed as adjunct therapy to the treatment of chronic
      periodontitis, showing good clinical and metabolic results in normoglycemic patients.
      Therefore, the aim of this study is to investigate the effectiveness of daily supplementation
      of omega-3 polyunsaturated fatty acids and low-dose aspirin as adjunct therapy to one-stage
      full-mouth periodontal ultrasonic debridement for the treatment of chronic periodontitis in
      type 2 diabetic patients through a superiority randomized clinical trial.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2016</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Periodontal pockets with mean probing depth (PD) ≥5mm</measure>
    <time_frame>Baseline, 90 days, 180 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Probing depth (mm)</measure>
    <time_frame>Baseline, 90 days, 180 days</time_frame>
    <description>Using a manual periodontal probe (North Carolina, HuFriedy, Chicago, IL, USA)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical attachment level (mm)</measure>
    <time_frame>Baseline, 90 days, 180 days</time_frame>
    <description>Using a manual periodontal probe (North Carolina, HuFriedy, Chicago, IL, USA)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gingival recession (mm)</measure>
    <time_frame>Baseline, 90 days, 180 days</time_frame>
    <description>Using a manual periodontal probe (North Carolina, HuFriedy, Chicago, IL, USA)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bleeding on probing (%)</measure>
    <time_frame>Baseline, 90 days, 180 days</time_frame>
    <description>Using a manual periodontal probe (North Carolina, HuFriedy, Chicago, IL, USA)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plaque index (%)</measure>
    <time_frame>Baseline, 90 days, 180 days</time_frame>
    <description>Using a manual periodontal probe (North Carolina, HuFriedy, Chicago, IL, USA)</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Glycated hemoglobin</measure>
    <time_frame>Baseline, 180 days</time_frame>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">75</enrollment>
  <condition>Diabetes Mellitus</condition>
  <condition>Chronic Periodontitis</condition>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Full-mouth periodontal debridement and placebo</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Test 1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Full-mouth periodontal debridement, 3g omega-3 plus 100mg aspirin daily for 60 days after periodontal therapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Test 2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>omega-3 plus aspirin before periodontal therapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>One-stage full-mouth periodontal ultrasonic debridement plus placebo intervention</description>
    <arm_group_label>Control Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>3g omega-3 plus 100mg aspirin daily for 60 days</intervention_name>
    <description>Full-mouth periodontal debridement, 3g omega-3 plus 100mg aspirin daily for 60 days after periodontal therapy</description>
    <arm_group_label>Test 1</arm_group_label>
    <other_name>omega-3 polyunsaturated fatty acids</other_name>
    <other_name>acetylsalicylic acid</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>omega-3 plus aspirin before periodontal therapy</intervention_name>
    <description>Full-mouth periodontal debridement, 3g omega-3 plus 100mg aspirin daily for 60 days before periodontal therapy</description>
    <arm_group_label>Test 2</arm_group_label>
    <other_name>omega-3 polyunsaturated fatty acids</other_name>
    <other_name>acetylsalicylic acid</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  a) Age ≥35 b) diagnosis of type 2 DM for ≥5 years c) DM treatment with oral
             hypoglycemic agents or insulin supplementation and diet d) glycated hemoglobin (HbA1c)
             levels from 6.5% to 11% e) at least 15 teeth (excluding third molars and teeth
             indicated for extraction) f) moderate to severe generalized chronic periodontitis
             (Armitage, 1999) g) agree and sign the formal consent to participate in the study
             after receiving an explanation of risks and benefits from an individual who is not a
             member of the study (Resolution number 196 - October, 1996, and Ethics and Code of
             Professional Conduct in Dentistry - CFO179/93).

        Exclusion Criteria:

          -  a) medical conditions that required prophylactic antimicrobial coverage b) scaling and
             root planing in the previous 6 months c) antimicrobial therapies in the previous 6
             months d) anti-inflammatory therapies in the previous 6 months e) systemic conditions,
             other than DM, that could affect the progression of chronic periodontitis f) current
             use of medication that could interfere with periodontal response to treatment g)
             pregnancy or lactation h) smoking
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mauro P Santamaria, PhD</last_name>
    <role>Study Director</role>
    <affiliation>UPECLIN HC FM Botucatu Unesp</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nidia C Santos, MS</last_name>
    <phone>5512991021346</phone>
    <email>nidia.santos@ict.unesp.br</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mauro P Santamaria, PhD</last_name>
    <phone>551239479379</phone>
    <email>mauro.santamaria@ict.unesp.br</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>UNESP</name>
      <address>
        <city>São José dos Campos</city>
        <state>SP</state>
        <zip>12245-000</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nidia C Santos, MS</last_name>
      <phone>5512991021346</phone>
      <email>nidia.santos@ict.unesp.br</email>
    </contact>
    <contact_backup>
      <last_name>Mauro P Santamaria, PhD</last_name>
      <phone>551239479379</phone>
      <email>mauro.santamaria@ict.unesp.br</email>
    </contact_backup>
    <investigator>
      <last_name>Cássia F Araujo, DDS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nídia C Santos, MS</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mauro P Santamaria, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <results_reference>
    <citation>El-Sharkawy H, Aboelsaad N, Eliwa M, Darweesh M, Alshahat M, Kantarci A, Hasturk H, Van Dyke TE. Adjunctive treatment of chronic periodontitis with daily dietary supplementation with omega-3 Fatty acids and low-dose aspirin. J Periodontol. 2010 Nov;81(11):1635-43. doi: 10.1902/jop.2010.090628. Epub 2010 Jun 23.</citation>
    <PMID>20572767</PMID>
  </results_reference>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 10, 2016</study_first_submitted>
  <study_first_submitted_qc>June 10, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 15, 2016</study_first_posted>
  <last_update_submitted>November 22, 2016</last_update_submitted>
  <last_update_submitted_qc>November 22, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 23, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidade Estadual Paulista Júlio de Mesquita Filho</investigator_affiliation>
    <investigator_full_name>Nídia Cristina Castro dos Santos</investigator_full_name>
    <investigator_title>DDS, MS</investigator_title>
  </responsible_party>
  <keyword>fatty acids</keyword>
  <keyword>aspirin</keyword>
  <keyword>diabetes mellitus</keyword>
  <keyword>chronic periodontitis</keyword>
  <keyword>periodontal debridement</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Periodontitis</mesh_term>
    <mesh_term>Chronic Periodontitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aspirin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

